Firefly Neuroscience Inc (AIFF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,810 | 1,230 | 244 | 563 | 2,143 |
| Receivables | 121 | 86 | 792 | 776 | 84 |
| TOTAL | $2,628 | $2,665 | $1,169 | $1,560 | $2,255 |
| Non-Current Assets | |||||
| PPE Net | 136 | 72 | 41 | 50 | N/A |
| Intangibles | 180 | 1,109 | 2,053 | 2,087 | 386 |
| Other Non-Current Assets | 1,657 | 1,465 | 47 | 69 | 0 |
| TOTAL | $1,973 | $2,646 | $2,141 | $2,205 | $386 |
| Total Assets | $4,601 | $5,311 | $3,310 | $3,765 | $2,641 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 300 | 500 | N/A |
| Accounts payable and accrued liabilities | 1,816 | 1,382 | 763 | 666 | 630 |
| Other current liabilities | 827 | N/A | 286 | 254 | N/A |
| TOTAL | $4,976 | $2,535 | $1,915 | $2,040 | $2,532 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 13 | N/A | N/A | N/A | N/A |
| TOTAL | $N/A | $N/A | $16 | $16 | $N/A |
| Total Liabilities | $4,976 | $2,535 | $1,931 | $2,056 | $2,532 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 11,623 | 8,503 | 7,341 | 671 | 671 |
| Common Shares | N/A | 1 | 0 | 2 | N/A |
| Retained earnings | -87,084 | -83,299 | -34,289 | -33,899 | -76,624 |
| Other shareholders' equity | 0 | 0 | 35 | 35 | 0 |
| TOTAL | $-375 | $2,776 | $1,379 | $1,709 | $109 |
| Total Liabilities And Equity | $4,601 | $5,311 | $3,310 | $3,765 | $2,641 |